We are live on
!
Find out more
RI
Ridgewood Investments Portfolio holdings
AUM
$267M
This Fund
S&P 500
This Quarter
Est. Return
+4.2%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$163M
AUM Growth
+$22.7M
(+16%)
Cap. Flow
+$22.4M
Cap. Flow
% of AUM
13.74%
Top 10 Holdings %
Top 10 Hldgs %
23.65%
Holding
833
New
632
Increased
56
Reduced
89
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$3.48M |
| 2 |
ALPS Medical Breakthroughs ETF
SBIO
|
+$851K |
| 3 |
RB Global
RBA
|
+$600K |
| 4 |
Baxter International
BAX
|
+$535K |
| 5 |
International Flavors & Fragrances
IFF
|
+$451K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$955K |
| 2 |
Cardinal Health
CAH
|
+$806K |
| 3 |
Deere & Co
DE
|
+$621K |
| 4 |
Kimberly-Clark
KMB
|
+$594K |
| 5 |
Goldman Sachs
GS
|
+$544K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.03% |
| 2 | Healthcare | 10.58% |
| 3 | Technology | 8.88% |
| 4 | Industrials | 7.49% |
| 5 | Consumer Discretionary | 6.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
NewtekOne
NEWT
$391M
| $347K | 0.21% |
+27,085
| New | +$447K |
|
127
Schwab International Equity ETF
SCHF
$68.7B
| $347K | 0.21% |
19,918
| – | – |
|
128
Ezcorp Inc
EZPW
$1.71B
| $344K | 0.21% |
40,000
-10,000
| -20% | -$87.9K |
|
129
Black Hills Corp
BKH
$5.69B
| $334K | 0.2% |
+5,300
| New | +$349K |
|
|
SCHR
130
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
| $332K | 0.2% |
13,162
| – | – |
|
131
Citizens Financial Group
CFG
$30.6B
| $326K | 0.2% |
10,719
-1
| -0% | -$39 |
|
132
Schwab 5-10 Year Corporate Bond ETF
SCHI
$11.5B
| $324K | 0.2% |
14,500
| – | – |
|
|
FITB
133
Fifth Third Bancorp
FITB
$51.8B
| $304K | 0.19% |
11,398
| – | – |
|
134
iShares Preferred and Income Securities ETF
PFF
$13.2B
| $302K | 0.19% |
9,684
| – | – |
|
135
Philip Morris
PM
$295B
| $302K | 0.18% |
3,104
+11
| +0.4% | +$1.1K |
|
136
Mativ Holdings
MATV
$711M
| $292K | 0.18% |
13,612
| – | – |
|
137
BRC Group Holdings
RILY
$289M
| $281K | 0.17% |
9,895
+41
| +0.4% | +$1.55K |
|
138
Sierra Bancorp
BSRR
$525M
| $278K | 0.17% |
16,127
+6,350
| +65% | +$128K |
|
|
EA
139
DELISTED
Electronic Arts
EA
| $276K | 0.17% |
+2,295
| New | +$270K |
|
140
Nutrien
NTR
$30.7B
| $275K | 0.17% |
+3,724
| New | +$287K |
|
141
Carter's
CRI
$1.47B
| $272K | 0.17% |
3,785
-1
| -0% | -$77 |
|
|
DOCU
142
DocuSign
DOCU
$11.5B
| $271K | 0.17% |
4,640
+470
| +11% | +$28K |
|
|
WSR
143
DELISTED
Whitestone REIT
WSR
| $270K | 0.17% |
29,388
| – | – |
|
|
144
Kimberly-Clark
KMB
$36.5B
| $266K | 0.16% |
1,982
-4,573
| -70% | -$594K |
|
145
Invesco Ultra Short Duration ETF
GSY
$3.88B
| $266K | 0.16% |
5,361
+1
| +0% | +$50 |
|
146
Royalty Pharma
RPRX
$25.3B
| $265K | 0.16% |
7,345
+1,975
| +37% | +$73.2K |
|
|
B
147
Barrick Mining
B
$73.2B
| $265K | 0.16% |
14,248
-10,913
| -43% | -$196K |
|
148
Progressive
PGR
$125B
| $262K | 0.16% |
1,831
| – | – |
|
149
NVIDIA
NVDA
$5.42T
| $261K | 0.16% |
9,390
-7,000
| -43% | -$151K |
|
150
Salesforce
CRM
$158B
| $259K | 0.16% |
+1,299
| New | +$219K |
|
Similar funds
IP
CFG
EU
PC
TGI
TWM
SP
EAIC
Ridgewood Investments's Q1 2023 Portfolio in Review
As of Q1 2023, Ridgewood Investments held 833 positions worth $163M, up 16% from $141M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ridgewood Investments deployed $22.4M of net new capital in Q1 2023, opening 632 new positions and adding to 56 existing holdings. Its largest new stake was ALPS Medical Breakthroughs ETF: 28,200 shares worth $21.9K.
By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 26% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $955K trimmed.
- Ridgewood Investments's largest Q1 2023 buy was ALPS Medical Breakthroughs ETF: 28,200 shares worth $21.9K.
- Ridgewood Investments added most to Vanguard Short-Term Treasury ETF in Q1 2023, an estimated $3.48M increase.
- Ridgewood Investments's biggest Q1 2023 reduction was Gilead Sciences, cutting an estimated $955K.
- Ridgewood Investments fully exited SRAX, Inc. Class A Common Stock in Q1 2023, selling an estimated $278K.
- Ridgewood Investments's ten largest holdings make up 24% of its $163M portfolio in Q1 2023.
- Ridgewood Investments opened 632 new positions and closed 4 in Q1 2023.
- Ridgewood Investments's portfolio value rose 16% quarter-over-quarter to $163M.
Based on Ridgewood Investments's 13F filing for Q1 2023, filed 25 Apr 2023.